Asthma and COPD Market Forecast
Published By: Datamonitor
June 2009
R313-52318
Online Download $15,200.00 Global Site License $38,000.00
Description

Introduction
Although the respiratory market has expanded considerably from 2004 to 2008, growth in the seven major markets is slowing down from 2009 to 2011, after which sales will decline due to patent expiries of leading brands. Growth is driven by the expansion of sales in existing classes, the launch of major new products with safety and convenience advantages, and the results of several landmark trials.
Reasons to Purchase- Identify key opportunities and threats that will impact the use and uptake of new and existing products
- Quantify the future size and scope of the asthma/COPD market and predict the performance of key compounds
- Understand critical success factors in growing and defending respiratory brand franchises from new entrants and generics
Please note: this is delivered as a Zip file.
|
Table of Contents
Please Note: Due to the brevity and/or nature of the content posted, there is no table of contents available for this report. |
Order Form * Please reference product number R313-52318 when ordering or inquiring.
MindBranch, Inc.,
131 Ashland St., Suite 200 North Adams, MA 01247
tel: 800-774-4410
fax: +1-413-664-9791
www.mindbranch.com
|